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Evaluating cognitive rehabilitation in 
multiple sclerosis: on the bumpy road 
to establishing evidence 
 
 
 
“Cognitive rehabilitation in multiple sclerosis is a  
steadily developing field of study. There is growing  
evidence for the effectiveness of cognitive  
rehabilitation in improving outcomes in people  
with multiple sclerosis.” 
Roshan das Nair*,1,2 
 
 
“There is marked enfeeblement of the 
memory; conceptions are formed slowly; 
the intellectual and emotional faculties are 
blunted in their totality,” Charcot (1877) 
reportedly noted about people with 
multiple sclerosis (MS) [1]. Despite these 
early observations of what we now refer 
to as ‘cognitive deficits’ and ‘mood 
disorders’, the magnitude and severity of 
these problems in MS were not consid-
ered seriously until over 100 years later. 
By the early 1990s, studies had begun to 
consistently demonstrate that people with 
MS reported cognitive problems. 
Cognitive problems in MS 
The presence of cognitive problems in 
people with MS has been reported to be in 
the range of 40–60% [2]. These problems 
have been found in all MS disease subtypes 
[3], in the incipient phase of MS [4] and on 
long-term follow-up [5]. There are some 
aspects of cognition that appear to be more 
affected than others, with attention, 
memory and executive functions 
(information processing speed, problem 
solving) being most affected. Language 
ability appears to be largely left intact, 
although some may experience anomia. 
Overall, there is considerable difference 
in the expression of these problems with 
people having varied and idiosyncratic 
cognitive profiles. 
There is growing consensus that cogni-
tive problems, apart from affecting peo-
ple’s activities of daily living and quality of 
life, can also place a large economic 
burden on the individual, families and the 
state. Indeed, some researchers assert that 
cognitive problems are “probably the 
most important determinant of employ-
ment status and associated societal costs” 
[6]. It is therefore unsurprising that in 2013 
the MS Society in the UK, along with the 
James Lind Alliance, identified treatments 
that are effective in improving cognition 
in people with MS, as one of their top ten 
research priorities. 
To develop these treatments, we may 
need to establish what causes or main-
tains these problems. In most neurologi-
cal conditions, examining pathophysi-
ology might be the first port of call. 
However, in MS, the pathophysiological 
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variance.” 
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“...double-blind, placebo  
controls, may not always  
be possible in randomized  
controlled trials of  
cognitive rehabilitation...” 
changes observed tend to be varied, and given 
their complexity, they are not fully understood 
[7]. Correlations between imaging and cognitive 
dysfunction have been variable and modest 
and only accounts for some of the variance. 
Researchers have, therefore, sought other 
explanations. 
More recently, researchers have examined 
the role of ‘cognitive reserve’ as a variable that 
might explain the high interindividual vari-
ability in cognitive deficits in MS (i.e., people 
with similar lesions and illness profiles may 
have very different cognitive profiles), and the 
variable correlations between MRI findings and 
cognitive problems in people with MS. 
Cognitive reserve refers to the “ability to opti-
mize or maximize performance through dif-
ferential recruitment of brain networks, which 
perhaps reflects the use of alternative cognitive 
strategies” [8]. This model implies that in people 
with high reserve, cognitive tasks are processed 
using less resources and in a way that makes 
errors unlikely to occur, in other words, more 
effectively. Much of the research on cognitive 
reserve has been conducted in the area of 
dementia. Sumowski and Leavitt [9] note that 
cognitive reserve is a function of ‘maximal life-
time brain growth’ (biology) and ‘intellectual 
enrichment’ (environment), and these protect 
against disease-related cognitive decline. This is 
an interesting avenue for MS research to 
pursue, particularly in terms of how ideas 
related to cognitive reserve can be incorporated 
in interventions designed to address cognitive 
problems or help people to live “‘brain healthy’ 
lifestyles” [9]. 
Cognitive rehabilitation 
One intervention to address cognitive dysfunc-
tion that has received much attention and has 
begun to attract research evidence is cognitive 
rehabilitation. Cognitive rehabilitation has been 
variously defined. My view is that it comprises 
therapeutic activities that are guided by theories 
and models of clinical and health psychology, 
and neuropsychology, that aims to reduce the 
impact of cognitive deficits, and to improve 
coping, function, psychological wellbeing, 
quality of life. While some interventions may 
strive to ‘improve’ cognitive performance, this 
is not seen as the primary goal of such 
rehabilitation [10]. 
Cognitive rehabilitation can also be defined 
based on content and mode of delivery. In  
terms of content, cognitive rehabilitation can 
involve direct retraining, which is normally 
cognitive domain-specific. Therefore, for 
instance, drill and practice exercises, repeated 
over several trials, are used to help people prac-
tice paying attention. For attention retraining 
this may include letter or number cancellation 
tasks, navigating through mazes, among others; 
or memory retraining may include tasks such as 
list-learning. Such training is linked to the 
theory of restitution or restoration of function, 
whereby through targeted and focused 
repeated stimulation, damaged neural networks 
are reactivated. Conversely, the content of 
cognitive rehabilitation could focus on teaching 
people to compensate for their difficulties 
using external and internal aids. For memory 
problems, for instance, people are taught to use 
visualization or generate acronyms to help 
remember things or activities (usually to be 
carried out at some point in the future). 
External aids, from ‘low-tech’ tools such as 
calendars, diaries and written lists, to more 
technological gadgets such as mobile phone 
and computers, can serve as useful memory 
aids. Mobile phone apps have also begun to be 
used to deal with certain problem solving 
issues. 
Cognitive rehabilitation, irrespective of 
whether the focus is on restitution or compen-
sation of lost function, most often begins with a 
comprehensive neuropsychological assessment. 
Such an assessment outlines the person’s 
cognitive profile of strengths and weaknesses, 
and cognitive rehabilitation capitalizes on the 
strengths to deal with the weaknesses. 
Finally, cognitive rehabilitation can be 
defined in terms of how it is delivered, in other 
words, whether in group settings or individu-
ally. Individually, this can include one-to-one 
therapy with a rehabilitation specialist, or it 
could be solely completed using computer soft-
ware. These delivery formats are combined in 
some instances. 
Effectiveness of cognitive rehabilitation 
in MS 
These different approaches to cognitive reha-
bilitation content and delivery formats have 
been researched, and based on this literature, 
Amato et al. [7] produced a position paper on the 
treatment of cognitive impairments in MS. 
Based on their review of literature, they con-
cluded that “behavioral techniques, designed to 
“...the goal of rehabilitation  
is to ultimately improve  
function.” 
improve information acquisition, have consist-
ently resulted in significant improvements in 
learning and memory performance,” and that 
“...targeted interventions can result in significant 
improvement in learning and memory, but the 
nature of the ‘targeted’ programme may be 
important.” However, the authors acknowledge 
that this was not a systematic review, and they 
only sampled some of the literature. They also 
added a caveat to these findings related to the 
methodological problems they observed within 
studies e valuating cognitive rehabilitation. 
The latest and most comprehensive system-
atic review and meta-analysis of neuropsycho-
logical rehabilitation in MS is the Cochrane 
Review by Otajärvi and Hämäläinen [10]. Their 
objective was to “assess the effects of 
neuropsy-chological/cognitive rehabilitation on 
health-related factors, such as cognitive 
performance and emotional well-being in 
patients with MS.” In this review of 20 studies 
(n = 966 people with MS) from ten different 
countries, 18 of 20 trials found a positive effect 
of the intervention compared with a control. 
When the data were meta-analyzed, the authors 
found that: When comparing cognitive training 
with any control, there were improvements in 
memory span and working memory; and when 
cognitive training and compensatory strategies 
were combined, compared with any control 
group, they found improvements in attention, 
immediate verbal memory and delayed 
memory. However, for both these strategies, 
there was no effect on some of the other basic 
cognitive functions, or indeed patients’ (or 
carers’) self-reported everyday cognitive 
performance, depression, anxiety, fatigue or 
quality of life. The authors concluded that their 
review “found low-level evidence for positive 
effects of neuropsycho-logical rehabilitation in 
MS ... new trials may therefore change the 
strength and direction of the evidence.” They 
too noted the methodological weakness of 
many of the studies included in their review. 
Based on eight trials (n = 521), our 2012 
Cochrane review [11] evaluating the effective-
ness of memory rehabilitation on functional 
outcomes found no evidence to support the 
effectiveness of memory rehabilitation on 
memory function or functional abilities in 
people with MS. However, this conclusion 
was because of the limited number and qual-
ity of some of the primary studies reviewed. 
In our current update [12] that includes 13  
trials (n = 786), we found that there is some 
evidence to support the effectiveness of mem-
ory rehabilitation on objectively measured 
memory function, as well as on quality of life. 
This is welcome news. However, the evidence 
is limited and effectiveness does not extend to 
subjective reports of memory functioning, 
activities of daily living or mood. Although 
compared with our previous review there was 
some improvement in the methodological 
quality of the studies, more work is required to 
raise the standard. 
In summary, small individual trials tend to 
demonstrate effectiveness of cognitive rehabili-
tation, however, meta-analyses of randomized 
controlled trials (RCTs) are more cautious in 
their conclusions. However, perhaps RCTs of c 
ognitive rehabilitation only tell one part of the 
story. 
Qualitative studies evaluating patient expe-
riences of such interventions have been posi-
tive. Our meta-synthesis [13] of five qualitative 
studies of memory rehabilitation (n = 87) 
found improvements in insight and acceptance 
of participants’ neurological condition and tak-
ing control over their cognitive problems; the 
therapeutic effects of the groups, with social 
support and leisure activities, improvements in 
memory and other psychological effects (such 
as mood, fatigue and confidence), and a 
positive impact on personal, interpersonal and 
professional lives. 
Discrepancy between qualitative 
& quantitative study findings 
The discrepancy in findings based on the 
methodology that studies use raises certain 
questions, highlight the challenges of 
conducting cognitive rehabilitation research 
in MS, but also suggests possible avenues for 
future research. 
 RCT methodology 
Some researchers have suggested that perhaps 
the RCT methodology is not the best way to 
evaluate complex interventions such as cognitive 
rehabilitation. Walach et al. [14] challenged the 
‘hierarchical model’ of evidence (with double 
blind, placebo controlled RCTs at the top of the 
hierarchy) to a ‘circular model’. This model 
advocates a multiplicity of methods, with dif-
ferent designs, that balances the strengths and 
weaknesses of each, to arrive at synthesized, 
pragmatic evidence. However, this model also 
“...small individual trials  
tend to demonstrate  
effectiveness of cognitive  
rehabilitation, however,  
meta-analyses of  
randomized controlled  
trials are more cautious in  
their conclusions.” 
advocates that each method is implemented 
with ‘optimal scientific rigor’. This is not always 
the case with RCTs of cognitive rehabilitation. 
Based on the above-mentioned literature 
reviews, some common problems with trials of 
cognitive rehabilitation in MS have been 
observed. It must, however, be noted that some 
of the studies included in all these reports are the 
same, so it is perhaps unsurprising, but also reas-
suring, that all authors have consistently picked 
up these problems. These include small sample 
sizes with studies not powered sufficiently to 
evaluate group differences, lack of or inadequate 
control groups, selection bias, inadequate ran-
domization and blinding protocols, outcomes 
lacking relevance to daily life, lack of long-term 
follow-up and poor reporting of trials. These 
problems are not specific to cognitive rehabili-
tation studies in MS, and have been reported in 
cognitive rehabilitation studies in other neuro-
logical conditions, for example, stroke [15]. Some 
of these issues are further discussed below. 
 Sample size 
Small sample sizes are common in cognitive 
rehabilitation trials of MS. In the Rosti-Otajärvi 
and Hämäläinen [10] review, samples sizes 
ranged from 15 to 240, with most trials having 
20–30 participants. Because of a lack of 
sensitive outcome measures, sample sizes in 
such trials need to be large. To some extent not 
having fully powered studies is understandable, 
because some of these trials were conducted 
with little or no funding, over short periods of 
time. We are currently recruiting to an UK 
National Institute for Health Research (NIHR) 
funded trial CRAMMS [16]. This pragmatic RCT 
aims to randomize 400 people with MS to 
either a manualised cognitive rehabilitation 
training group intervention or usual care 
control. Further trials, evaluating other types of 
cognitive rehabilitation, should be of this 
magnitude; suitably powered to be c onfident of 
the statistical findings. 
 Control groups 
Suitable control groups are essential for RCTs, 
and in complex interventions, such as cognitive 
rehabilitation, it is not always possible to have 
‘active’ control groups. Most studies tend to 
use a ‘treatment as usual’ control, but some 
have tried delivering control activities with 
limited intervention content (e.g., use of a 
‘placebo’ computerized program vs an active 
computerized memory retraining program). In 
one of our trials of memory rehabilitation [17], 
we delivered an ‘attention placebo’ or ‘self-help’ 
control, wherein the control group spent the 
same amount of contact time with the 
facilitator as the intervention groups, but the 
participants only engaged in group discussions 
about their problems and learned relaxation 
techniques. Through time sampling, we were 
able to demonstrate that there was a significant 
difference in terms of the content of the 
intervention groups and the control group (i.e., 
control group had very little discussion around 
cognitive problems), so we were confident that 
only the intervention groups were receiving the 
active components of the intervention [18]. 
However, these groups were difficult to run and 
participants were aware that they were not 
getting the intervention. Despite this, they 
continued to attend the groups and participant 
feedback showed that even those in the control 
group benefited from the group activity [19]. 
This may therefore have dampened the 
possibility of finding significant differences 
between groups on quantitative outcome meas-
ures. Therefore, reviewers not familiar with 
cognitive rehabilitation should be mindful that 
double-blind, placebo controls, may not always 
be possible in RCTs of cognitive rehabilitation. 
 Outcomes 
The desired primary outcome of cognitive 
rehabilitation has been debated [20,21], and 
studies have either chosen a ‘neuropsychologi-
cal’ measure or a ‘functional’ measure. In our 
Cochrane review of memory rehabilitation [12], 
the objective measures used by most trials were 
list learning tasks (such as Hopkins Verbal 
Learning Test, Auditory Verbal Learning Test, 
and California Verbal Learning Test). While 
these tests have good diagnostic and predictive 
value, they have limited ecological validity as 
outcome measures of rehabilitation, thus 
potentially limiting the generalizability of 
findings into daily life. 
Another point to consider is the psychomet-
ric properties of some of these measures. For 
instance, Rasch analysis of the Nottingham 
Extended Activities of Daily Living scale, a 
scale widely used in clinical practice and 
rehabilitation research, did not find support for 
the total scale as a unidimensional measure of 
activities of daily living. There were differential 
item functioning for age and for gender 
on some items [22]. Rasch analysis has been 
recommended for the development of new, and 
evaluation of current scales used in rehabilita-
tion, and more such research on commonly 
used scales is needed. 
A systematic review [23] found that Goal 
Attainment Scaling (GAS) is a sound measure 
for physical, neurological and geriatric reha-
bilitation settings. However, our experience of 
applying it as an outcome measure in RCTs 
has been fraught with challenges. Challenges 
have included clients’ goals not remaining 
static over time (sometimes outcomes are con-
ducted 12–18 months after randomization to 
evaluate the longevity of intervention effec-
tiveness); keeping outcome assessors blind to 
group allocation becomes difficult whereby the 
more time assessors spend with people with 
memory problems, the greater the chance that 
they will become unblinded; and Tennant [24] 
identified some scientific and measurement 
challenges posed by GAS, but also provided 
some helpful solutions. 
I share Wilson’s [25] assertion that standard-
ized neuropsychological tests are not the best 
outcome measures for evaluations of cognitive 
rehabilitation, because the goal of rehabilitation 
is to ultimately improve function. Using the 
International Classification of Functioning, 
Disability and Health (ICF) [26], we can classify 
outcomes associated with impairments, activity 
limitations and participation restrictions, and 
the desired outcome of cognitive rehabilitation 
straddles the latter two categories. 
 Reporting 
Quality of reporting of trials of complex inter-
ventions has perhaps improved with the adop-
tion of the CONSORT statement [27], but 
cognitive rehabilitation has been insufficiently 
described by trialists [28,29]. This makes it dif-
ficult for researchers to replicate studies and for 
clinicians to implement them in practice. The 
recently published Template for Intervention 
Description and Replication (TIDieR) checklist 
[30] and more cognitive rehabilitation-specific 
guidelines [28,29] may improve the quality of 
reporting such interventions, particularly if 
journal editors recommend that such guidance 
is followed. 
 Effectiveness 
Finally, we need to acknowledge that cognitive 
rehabilitation may not be effective for everyone 
with MS. Currently, we have limited knowledge 
about who benefits most from cognitive 
rehabilitation, when in the patient’s journey it is 
best to offer such an intervention, and for how 
long. Indeed, without routine screening for 
cognitive problems in MS, it may be difficult to 
identify people early after diagnosis to provide 
them with rehabilitation if they experience 
cognitive problems. Langdon et al. recommend 
the Brief International Cognitive Assessment 
for Multiple Sclerosis (BICAMS) as a suitable 
screening tool [6]. The value of this tool in 
effecting systemic changes in healthcare 
provision and ultimately improved patient 
outcomes is yet to be established, and such an 
assessment is urgently needed. 
Conclusion 
Cognitive rehabilitation in MS is a steadily 
developing field of study. There is growing evi-
dence for the effectiveness of cognitive rehabil-
itation in improving outcomes in people with 
MS. Researchers are, however, still exploring 
what the focus and content of such rehabilita-
tion should be, how and when the intervention 
can be delivered, how the intervention works (if 
it works), how change and effectiveness can be 
assessed using process and outcome measures, 
and whether or not cognitive rehabilitation in 
MS is clinically effective and cost effective. 
Large trials such as CRAMMS may provide the 
answers to the latter question on effectiveness, 
but the jury is still out on many of these issues. 
More well-conducted and reported trials are 
required, but equally, the ‘black-box’ of 
cognitive rehabilitation needs to be scrutinized 
and detailed analyses of the mechanisms of 
change need to be investigated. We have been 
on this road for some time and much has been 
learned, but in some respects, the journey has 
only just begun. 
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